'Kerching!' For Companies That Change – And Change Effectively
Executive Summary
European medtech companies are changing the way they do business. These new business models are enabling them to overcome market challenges and will allow them to keep growing their business if successfully implemented, an industry survey by Simon-Kucher & Partners has revealed.
You may also be interested in...
Medtech Sales Not Fully Reaping Rewards Of Digitalization, Industry Survey Reveals
The digital revolution is happening not only in the R&D department of medtech companies but also within firms' sales organizations, with the goal of increasing efficiencies and boosting the top line. However, according to results from an industry survey, while most medtech firms say they are investing in digital sales tools and implementing them into the sales infrastructure, they are not seeing the hoped-for results.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.